Biotech

All Articles

Acelyrin loses izokibep, drops 3rd of team

.Despite izokibep maintaining its own newly found winning streak in the clinic, Acelyrin is actually...

Rivus' stage 2 obesity-related heart failure test reaches endpoint

.Rivus Pharmaceuticals has plumped up the leads of its fat-busting, muscle-sparing medicine candidat...

Ovid halts preclinical job, IV plan after soticlestat neglect

.Ovid Therapy already exposed last month that it was actually trimming back its own headcount as the...

Eli Lilly opens up $700M nucleic acid R&ampD facility in Boston ma Port

.Eli Lilly has opened up a $700 thousand R&ampD facility in the Boston Seaport, increasing its own R...

Boundless Bio makes 'reasonable' layoffs 5 months after $100M IPO

.Just 5 months after protecting a $one hundred thousand IPO, Boundless Biography is currently laying...

Halda's $126M will certainly accelerate 'hold as well as get rid of' cyst drugs

.The first stages of oncology R&ampD may not be short of interesting brand-new techniques, and also ...

Lykos 'remorses' certainly not revealing study infractions along with publisher

.Psychopharmacology has drawn three posts about midstage medical trial data assessing Lykos Therapie...

Analysts go into Avidity's DMD succeed, revealing nuances in records

.Avidity Biosciences satisfied clients with stage 1/2 records in Duchenne muscular dystrophy (DMD) F...

Actinogen's cortisol blocker neglects period 2 anxiety research study

.Actinogen Medical's cortisol blocker has actually missed out on the key endpoint of a stage 2 resea...

Bivictrix determines going exclusive only way to take ADC into facility

.Antibody-drug conjugates (ADCs) have gone to the facility of lots of a billion-dollar biobuck licen...